: Flow chart of the differentiation procedure with subsequent drug testing. hiPSC are seeded into multi-well plates on day 0. On day 1 the differentiation medium containing BMP2 and BMP7 is added. The cells differentiate during the following week into HPTC-like cells and can be used for drug testing in the evening of day 8. After drug exposure over night the cell lysates are harvested in the morning of day 9 for determining IL6 and IL8 levels by qPCR. Alternatively, cells can be fixed and stained in the morning of day 9 in the micro-well plate used for cell differentiation and used for analysis with automated cellular imaging. nephrotoxicants that do not damage PTC directly and compounds 27-30 are not nephrotoxic in humans. Each compound was applied at concentrations of 1 µg/ml, 10 µg/ml, 100 µg/ml and 1,000 µg/ml. 0 represents the vehicle control (compound concentration: 0 µg/ml). IL6 expression levels were determined by qPCR on the morning of d9. In some cases IL6 expression levels could not be determined (ND) due to massive cell death. The results show the mean +/-s.d. (n = 3). All results were normalized to the respective vehicle controls and the means of the vehicle controls were set to 1.
